CRISPR is already in clinical use and most people don't realize
The first CRISPR-based therapy (for sickle cell disease) was approved in late 2023. Gene editing went from 'maybe in 50 years' to 'FDA-approved' faster than almost anyone predicted.
The first CRISPR-based therapy (for sickle cell disease) was approved in late 2023. Gene editing went from 'maybe in 50 years' to 'FDA-approved' faster than almost anyone predicted.